Common use of Your Successors Clause in Contracts

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxx, Xxxxxx, XX 00000 | T: 617.225.0096 Xxxxxxx, Xxxxxx March 9, 2020

Appears in 1 contract

Samples: Assignment Agreement (Proteostasis Therapeutics, Inc.)

AutoNDA by SimpleDocs

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make Proteostasis Therapeutics, Inc. | 000 Xxxxxxxxxx Xxxxxx, Xxxxxx Xxxxx, Xxxxxxxxx, XX 00000 | T: 617.225.0096 Po-Xxxx Xxx, M.D. March 11, 2016 such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxx, Xxxxxx, XX 00000 | T: 617.225.0096 Xxxxxxx, Xxxxxx March 9, 2020.

Appears in 1 contract

Samples: Separation Agreement and Release (Proteostasis Therapeutics, Inc.)

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxx, Xxxxxx, XX 00000 | T: 617.225.0096 Xxxxxxx, Xxxxxx [Name] March 9__, 2020

Appears in 1 contract

Samples: Assignment Agreement (Proteostasis Therapeutics, Inc.)

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxx, Xxxxxx, XX 00000 | T: 617.225.0096 XxxxxxxXxxxx, Xxxxxx March 9, 2020

Appears in 1 contract

Samples: Assignment Agreement (Proteostasis Therapeutics, Inc.)

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make Proteostasis Therapeutics, Inc. | 000 Xxxxxxxxxx Xxxxxx, Xxxxxx Xxxxx, Xxxxxxxxx, XX 00000 | T: 617.225.0096 Xxxxx XxXxxx August 4, 2016 Page 13 of 18 such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxx, Xxxxxx, XX 00000 | T: 617.225.0096 Xxxxxxx, Xxxxxx March 9, 2020.

Appears in 1 contract

Samples: Separation Agreement and Release (Proteostasis Therapeutics, Inc.)

AutoNDA by SimpleDocs

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Proteostasis Therapeutics, Inc. | 200 Xxxxxxxxxx Xxxxxx, Xxxxxx Xxxxx, Xxxxxxxxx, XX 00000 | T: 617.225.0096 Po-Sxxx Xxx, M.D. October 21, 2016 Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxx, Xxxxxx, XX 00000 | T: 617.225.0096 Xxxxxxx, Xxxxxx March 9, 2020.

Appears in 1 contract

Samples: Separation Agreement and Release (Proteostasis Therapeutics, Inc.)

Your Successors. The terms of this Agreement will inure to the benefit of and be enforceable by your personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of your death prior to the completion by the Company of all payments due hereunder, the Company shall continue such payments to any beneficiary designated in writing to the Company prior to your death (or to your estate, if you do not make such designation). This Agreement shall be binding upon you and your successors, permitted assigns, personal representatives, executors, administrators, heirs, distributees, devisees and legatees. Except to the extent contemplated under this Section 10, you may not assign this Agreement nor any of your rights or obligations under this Agreement, whether voluntarily, by operation of law or otherwise, without the prior written consent of the Company. Proteostasis Therapeutics, Inc. | 00 Xxxxx 000 Xxxxxxxxxx Xxxxxx, Xxxxx 000, Xxxxx Xxxxxx Xxxxx, XxxxxxXxxxxxxxx, XX 00000 | T: 617.225.0096 XxxxxxxXxxxx Xxxxxxxx Sent on July 13, Xxxxxx March 9, 20202017 Page 13 of 18

Appears in 1 contract

Samples: Separation Agreement and Release (Proteostasis Therapeutics, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.